Loading...

PODCAST

The BioHub - by Avetix

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:26:14

Episode 203 - Tim Noyes - CEO of Newleos Therapeutics

The BioHub - by Avetix ·

2026/07/20

In this episode of The BioHub Podcast, Ben is joined by Tim Noyes, President and CEO of Newleos Therapeutics.Tim reflects on more than 35 years across the life sciences industry, from beginning his career at Merck to building and leading emerging biotechnology companies. He shares why he has consistently been drawn to smaller organisations, where leadership teams can remain close to the science, the patients and the people driving the company forward.The conversation explores Newleos’ mission to

en

00:33:33

Episode 202 - Ben Swanson - CEO of Skeletalis

The BioHub - by Avetix ·

2026/07/16

Today we're joined by Ben Swanson, Founder and CEO of Skeletalis, a biotechnology company developing a new generation of precision medicines for bone disease.Ben's path into biotech is anything but conventional. Trained as both a dentist and a scientist, he founded Skeletalis to tackle one of the biggest unmet challenges in musculoskeletal health: how to deliver treatments directly to the parts of the skeleton that need them most, while minimizing effects on the rest of the body.At

en

00:23:31

Episode 201 - Bennett Smith - SVP Commercial Beren...

The BioHub - by Avetix ·

2026/07/14

In this episode of The BioHub Podcast, Max sits down with Bennett Smith, Senior Vice President of Commercial at Beren Therapeutics.Bennett has spent more than two decades building commercial organisations and bringing innovative medicines to patients, holding leadership roles at Novo Nordisk, Regeneron, Akebia, and Orchard Therapeutics, where he helped launch one of the world's most expensive gene therapies.Today, he's leading commercial strategy at Beren Therapeutics, a clinical-stage

en

00:30:45

Episode 200 - Tassos Gianakakos & Liz Nguyen - Kardigan

The BioHub - by Avetix ·

2026/07/14

What's the right team to build a precision cardiovascular biopharma company?In this episode Tassos Gianakakos CEO and Chief People Officer Liz Nguyen discuss how Kardigan is thinking about talent, culture, and the capabilities required to bring precision medicine to cardiovascular disease.

en

00:28:01

Episode 199 - Miles Gerson - Partner at SV Health...

The BioHub - by Avetix ·

2026/07/13

In this episode of The BioHub Podcast, Ben sits down with Miles Gerson, Partner at SV Health Investors and Co-Lead of the Dementia Discovery Fund.Miles shares his perspective on investing in neuroscience, building companies around emerging biology and identifying approaches with the potential to change the treatment landscape in dementia and neurodegenerative disease.The conversation explores how the Dementia Discovery Fund assesses scientific risk, what makes a neuroscience company investable,

en

00:25:48

Episode 198 - Andrew Obenshain - CEO Inventiva

The BioHub - by Avetix ·

2026/07/10

In this episode of The BioHub Podcast, Max sits down with Andrew Obenshain, CEO of Inventiva.Andrew brings more than 20 years of experience across global drug development, regulatory strategy, and commercialization. Before joining Inventiva, he led bluebird bio through its transformation into a global commercial-stage gene therapy company and previously held senior leadership roles at Shire and Genzyme.Inventiva is a late-stage clinical biopharmaceutical company developing oral therapies for

en

00:33:32

Episode 197 - Eduardo Bravo - CEO of Citryll

The BioHub - by Avetix ·

2026/07/07

Today, I'm delighted to welcome Eduardo, CEO of Citryll Therapeutics. Eduardo has built his career at the intersection of science, innovation, and business, leading the development of transformative therapies designed to address serious autoimmune and inflammatory diseases.With extensive experience in the biotechnology industry, Eduardo has played a key role in guiding companies from scientific discovery through clinical development and strategic growth. As CEO of Citryll Therapeutics, he is

en

00:44:12

Episode 196 - Michael Rome - Managing Director at...

The BioHub - by Avetix ·

2026/07/06

In this episode of The BioHub Podcast by Avetix, Ben is joined by Michael Rome, Managing Director at Foresite Capital.Michael brings a unique perspective across biotech investing, company formation, therapeutics strategy, and public markets. The conversation explores how great biotech companies are built, what separates strong science from a fundable opportunity, and how investors think about timing, team, differentiation, and value creation.We also discuss the current biotech market, the evolving

en

00:39:17

Episode 195 - Luke Henry - CBO/COO at Quell Therapeutics

The BioHub - by Avetix ·

2026/07/03

Today, I'm delighted to welcome Luke Henry, Chief Business Officer and Chief Operating Officer at Quell Therapeutics, a company at the forefront of engineering the next generation of regulatory T cell, or Treg, therapies for immune-mediated diseases.Quell is pioneering a new approach to treating autoimmune and inflammatory diseases, as well as improving outcomes in organ transplantation. Rather than suppressing the entire immune system, the company's engineered Treg therapies are designed to

en

00:29:19

Episode 194 - Rick Batycky - CEO at Nocion Therapeutics

The BioHub - by Avetix ·

2026/06/29

Rick Batycky, CEO of Nocion Therapeutics, joins The BioHub Podcast by Avetix to discuss the company’s work in chronic cough and neurogenic inflammation.Rick talks about the scale of the unmet need in chronic cough, why the condition remains so difficult to treat, and how Nocion is approaching the biology differently. He also shares insight into the company’s lead programme, its upcoming pivotal-stage development, and what successful execution could mean for patients who currently have limited

en

00:20:09

Episode 193 - Patrick Mooney - CEO of SpyGlass Pharma

The BioHub - by Avetix ·

2026/06/25

Welcome back to another episode of the BioHub Podcast.Today, we're delighted to be joined by Patrick Mooney, CEO of SpyGlass Pharma.Patrick has built an impressive career in ophthalmology, beginning in sales and progressing through a variety of leadership roles to become one of the industry's most respected executives.At SpyGlass Pharma, the mission is simple: put patients first. The company is developing innovative technology designed to transform the treatment of eye diseases, with the

en

00:28:19

Episode 192 - Sandeep Kulkarni - CEO Zura Bio

The BioHub - by Avetix ·

2026/06/19

In this episode of The BioHub Podcast, Max sits down with Dr. Sandeep Kulkarni, Co-Founder and CEO of Zura Bio.Sandeep's career has spanned consulting, investing, and operating roles across biotech, including positions at BCG, Roivant, and Immunovant, before going on to co-found Tourmaline Bio and now lead Zura Bio.Zura is a clinical-stage biotechnology company focused on developing novel therapies for autoimmune and inflammatory diseases through a differentiated multi-asset strategy.In this

en

00:18:56

Episode 191 - Trevor Martin - Co-Founder & CEO...

The BioHub - by Avetix ·

2026/06/19

In this episode of The BioHub, Amber is joined by Trevor Martin, Co-Founder and CEO of Mammoth Biosciences.Mammoth Biosciences is developing next-generation CRISPR technologies with the goal of unlocking the full potential of programmable medicine. Founded alongside Nobel Prize winner Jennifer Doudna, the company has built a platform focused on discovering and engineering novel CRISPR systems for both diagnostic and therapeutic applications.During the conversation, Trevor shares the story behind

en

00:31:13

Episode 190 - Sean MacDonald - CEO Kainova Therapeutics

The BioHub - by Avetix ·

2026/06/17

In this episode of The BioHub Podcast, Max sits down with Sean MacDonald, CEO of Kainova Therapeutics.Sean has spent more than two decades in biotech, helping build companies through strategy, fundraising, business development, and corporate leadership. Today, he leads Kainova Therapeutics, a clinical-stage company focused on unlocking the potential of GPCR biology in immuno-oncology and inflammatory diseases.In this conversation, we discuss the evolution of Kainova from Domain Therapeutics, the

en

00:20:39

Episode 189 - Cameron Pitt - Co-founder & COO Quanta...

The BioHub - by Avetix ·

2026/06/15

In this episode of The BioHub Podcast, Max sits down with Cameron Pitt, Co-Founder and COO of Quanta Therapeutics.Cameron's career has taken him from academic research at Stanford and UCSF, to venture investing at Versant Ventures and Sofinnova Investments, before helping form and build Quanta Therapeutics from the ground up.Quanta is focused on one of the biggest challenges in oncology: targeting RAS-driven cancers. Using a novel approach designed to restore control of RAS signalling, the

en

00:30:27

Episode 188 - Geert Kersten - CEO of CEL-SCI

The BioHub - by Avetix ·

2026/06/11

In this episode of The BioHub Podcast, Max sits down with Geert Kersten, Chairman and CEO of CEL-SCI Corporation.Geert has led CEL-SCI for nearly three decades, overseeing the development of the company's lead immunotherapy candidate, Multikine, and navigating one of the longest and most challenging journeys in biotech.In this conversation, we discuss the realities of building a biotech company over the long term, the persistence required to advance innovative therapies, and Geert's perspective on

en

00:27:25

Episode 187 - Leonard Mazur - CEO Citius Pharma

The BioHub - by Avetix ·

2026/06/10

In this episode of The BioHub Podcast, Max sits down with Leonard Mazur, Chairman and CEO of Citius Pharmaceuticals.Leonard is a seasoned entrepreneur and pharmaceutical executive who has spent decades building, scaling, and commercializing healthcare companies. Throughout his career, he has founded multiple successful businesses, led major transactions, and helped bring innovative therapies to patients across a range of therapeutic areas.In this conversation, we discuss Leonard's journey as a

en

00:35:18

Episode 186 - Derek Small - Founder, Managing...

The BioHub - by Avetix ·

2026/06/06

In this episode of The BioHub Podcast, Max sits down with Derek Small, Founder and Managing Director of Luson Bioventures.Over the past two decades, Derek has built a reputation as one of biotech's leading venture creators, founding and leading multiple companies across neuroscience and CNS drug development. Through Luson, he has helped launch, finance, and scale businesses from inception, raising more than $1 billion in capital along the way.In this conversation, we discuss the differences between

en

00:24:46

Episode 185 - Ed Ahn - Medipost INC

The BioHub - by Avetix ·

2026/06/05

Today's guest is Edward Ahn, CEO of MEDIPOST Inc., a biotechnology company at the forefront of regenerative medicine and stem cell therapeutics. Based in Cambridge, Massachusetts, MEDIPOST is leading the global development of innovative cell therapies designed to address inflammation-driven degenerative diseases, with a mission to move beyond symptom management and toward true disease modification.Edward leads MEDIPOST's U.S. operations and global expansion efforts for CARTISTEM®, the

en

00:29:02

Episode 184 - Randy Teel - President & CEO Arvinas

The BioHub - by Avetix ·

2026/06/04

In this episode of The BioHub Podcast, Max sits down with Randy Teel, President and CEO of Arvinas.Randy joined Arvinas in 2018 as Vice President of Corporate Development and has since helped guide the company through a period of significant growth, ultimately stepping into the CEO role. Today, Arvinas is one of the pioneers in targeted protein degradation, using its PROTAC platform to develop therapies designed to eliminate disease-causing proteins.In this conversation, we discuss Randy’s journey

en

269 results

Similar Podcasts

Planetterrian Daily

Patrick · Nerra Network

New Books in Science, Technology, and Society

New Books Network

Scifi Friday

Radio Memories Network

The Bio Report

Levine Media Group

Waterlines: How Water Shapes Our World

jaywen